Riskpilot← Back to searchSign inGet full accessProTreatment Jorcks Passage ApS
APSActiveCVR 39480654Skindergade 31, 2.Physiotherapy activities · NACE 8695Est. 20188 employees
Revenue 2024
DKK 3,7M
-29% vs 2023
EBITDA margin
-8.4%
-124% vs 2023
Equity ratio
-70.2%
Financial strength
Net profit 2024
DKK -1,2M
-606% vs 2023
| Revenue | DKK 3,7M | -29% |
| EBITDA | DKK -305K | -124% |
| Net profit | DKK -1,2M | -606% |
| Total assets | DKK 7,2M | -17% |
| Equity | DKK -5M | -32% |
| Employees | 8 | — |
Legal name
ProTreatment Jorcks Passage ApS
CVR number
39480654
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
11. april 2018
Share capital
DKK 50.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller den samlede direktion.
Company purpose
Selskabets formål er at drive fysioterapeutklinik og hermed ligestillet virksomhed.
Address
Skindergade 31, 2.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.483 | 3.100 | 2.907 | 3.695 | 3.906 | 5.126 | 3.654 |
| Staff expenses | -2.041 | -2.724 | -2.264 | -2.910 | -2.828 | -3.636 | -3.817 |
| EBITDA | 442 | 375 | 643 | 786 | 586 | 1.263 | -305 |
| Depreciation & amort. | -651 | -1.182 | -1.244 | -1.244 | -1.244 | -939 | -720 |
| EBIT | -209 | -806 | -600 | -458 | -657 | 324 | -1.025 |
| Net financials | -472 | -477 | -339 | -319 | -349 | -547 | -549 |
| Profit before tax | -681 | -1.284 | -939 | -777 | -1.006 | -224 | -1.574 |
| Tax | -110 | -282 | -207 | -171 | -221 | -50 | -346 |
| Net profit | -571 | -1.001 | -733 | -606 | -785 | -174 | -1.228 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 11.904 | 12.795 | 11.598 | 10.429 | 9.553 | 8.618 | 7.190 |
| Equity | -521 | -1.522 | -2.255 | -2.861 | -3.646 | -3.820 | -5.048 |
| Long-term debt | 9.606 | 12.471 | 10.618 | 10.029 | 9.808 | 6.487 | 7.107 |
| Short-term debt | 2.647 | 1.528 | 2.890 | 2.947 | 3.106 | 5.623 | 4.933 |
| Total debt | 12.253 | 13.999 | 13.508 | 12.976 | 12.914 | 12.110 | 12.040 |
EBITDA margin
-8.4%
This company
15.8%
Market median
-153% vs market
20182024
Equity ratio
-70.2%
This company
38.2%
Market median
-284% vs market
20182024
Return on equity
-122818100.0%
This company
18.4%
Market median
-667489774% vs market
20182024
Net profit margin
-33.6%
This company
8.1%
Market median
-515% vs market
20182024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20182024
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-04-11 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment Jorcks Passage ApS Board members of ProTreatment Jorcks Passage ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |